📰 Cochlear Limited News
Page 4 - Cochlear Limited News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cochlear Limited. Real-time updates on events, politics, business and more.
October 25, 2023
Regulatory News: Sensorion (FR0012596468 – ALSEN) (PARIS:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field
October 25, 2023
MONTPELLIER, France--(BUSINESS WIRE)--Oct 25, 2023--
October 25, 2023
Press release Sensorion to Participate in the Jefferies London Healthcare Conference and McDermott Will & Emerys Life Sciences Symposium ...
October 23, 2023
Cochlear Limited (ASX:COH – Get Free Report) insider Karen Penrose acquired 138 shares of the business’s stock in a transaction dated Wednesday, October 18th. The stock was acquired at an average price of A$252.80 ($160.00) per share, for a total transaction of A$34,885.99 ($22,079.74). Karen Penrose also recently made the following trade(s): On Tuesday, September […]
October 20, 2023
Key Insights Institutions' substantial holdings in Cochlear implies that they have significant influence over the...
October 12, 2023
Cochlear Limited (OTCMKTS:CHEOY – Get Free Report) saw a large decline in short interest in the month of September. As of September 30th, there was short interest totalling 3,700 shares, a decline of 79.3% from the September 15th total of 17,900 shares. Based on an average daily volume of 16,800 shares, the days-to-cover ratio is […]
October 4, 2023
Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make...
October 1, 2023
Cochlear Limited (OTCMKTS:CHEOF – Get Free Report) was the target of a large drop in short interest in September. As of September 15th, there was short interest totalling 85,300 shares, a drop of 13.6% from the August 31st total of 98,700 shares. Based on an average trading volume of 1,100 shares, the short-interest ratio is […]
September 26, 2023
26.09.2023 - Regulatory News: Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing loss disorders, Sensorion ...
September 20, 2023
MONTPELLIER, France--(BUSINESS WIRE)--Sep 20, 2023--